Baseline and 12-weeks follow-up assessment consisted of the Beck Depression Inventory-II (BDI-II) for depression, blood sample for BDNF, respectively the short-Form-36 (SF-36) version 1.0 and disease-specific QoL for QoL. Here, BDNF is linked to depressive symptom measurement.